CID 355584

N-(2-ethyl-3-methyl-1-phenyl-3-pyrazolin-5-ylidene)salicylamide

Structural Information

Molecular Formula
C19H19N3O2
SMILES
CCN1C(=CC(=NC(=O)C2=CC=CC=C2O)N1C3=CC=CC=C3)C
InChI
InChI=1S/C19H19N3O2/c1-3-21-14(2)13-18(22(21)15-9-5-4-6-10-15)20-19(24)16-11-7-8-12-17(16)23/h4-13,23H,3H2,1-2H3
InChIKey
VNCOWZFHARHZND-UHFFFAOYSA-N
Compound name
N-(1-ethyl-5-methyl-2-phenylpyrazol-3-ylidene)-2-hydroxybenzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

321.14774 Da
Monoisotopic Mass

4.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 322.155016 176.2
[M+Na]+ 344.136958 184.8
[M-H]- 320.140464 184.3
[M+NH4]+ 339.181563 189.3
[M+K]+ 360.110898 179.4
[M+H-H2O]+ 304.145000 166.3
[M+HCOO]- 366.145941 199.2
[M+CH3COO]- 380.161591 209.8
[M+Na-2H]- 342.122406 177.8
[M]+ 321.14719142 177.8
[M]- 321.14828858 177.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.